$OPGN Hopefully we have a similar story to Voyager therapeutics. It was trading at $2.47, similar to Opgen and both companies have around 38M shares outstanding, Voyager is now $5.50/share after signing a deal with Pfeizer for them to use their capsid technology, upfront payment of 30M cash with milestones etc. Point is, this is what we need guys, we need a near term PR with upfront cash...maybe not 30M cash but i can see something like 10-12M cash, this would be Qiagen/Thermo Fischer or whomever has the means to run the AMR panel on their Quant studio. Here is the PR from Voyager, check it out. barrons.com/articles/voyage...
Beaten-Down Biotech Soars on Pfizer License Dealvia: Barrons